Future of Insurance article points to the ongoing concern for how the insurance industry continues to manages casualty catastrophe, specifically emerging risks and highlights how Praedicat is transforming product stewardship…
read moreFilter posts by:
Allianz Global Corporate & Specialty (AGCS) has joined hands with Praedicat to predict with increased accuracy the key catastrophe liability risks ahead. AGCS liability underwriters use Praedicat’s data analysis tools…
read moreBob Reville, Praedicat’s CEO, is featured on an episode of Profiles in Risk, a weekly podcast hosted by Nick Lamparelli. In this interview, Bob discusses emerging risk, casualty catastrophes and…
read moreAllianz Global Corporate & Specialty and Praedicat published the first in a series of reports looking at emerging liability risks. This white paper examines nanotechnology and its applications to the…
read moreAllianz Global Corporate & Specialty SE (AGCS), the corporate insurance carrier of Allianz SE, is working with Praedicat, the InsurTech analytics company based in Los Angeles, to better predict the…
read moreHow can we gain insight into emerging risks? At the Risk and Insurance Management Society (RIMS) Annual Conference & Exhibition in Philadelphia, Robert Reville, CEO of Praedicat, and Anna Pierce,…
read moreCoMeta™ Life Science adds pharmaceutical Litagion® agent profiles to CoMeta focusing on evaluating the liability that could arise from a manufacturer’s failure to warn physicians regarding the risk of specific…
read moreIn February 2017, Dupont and Chemours, a DuPont spin-off, settled over 3,000 pending lawsuits brought by Ohio and West Virginia residents who claimed they were sickened by contaminated drinking water[1].…
read morePraedicat, an InsureTech analytics company based in Los Angeles, California, is pleased to announce today that it has licensed Oortfolio™, its casualty catastrophe modeling solution, to Tokio Millennium Re AG…
read morePraedicat’s new modeling capabilities in the pharmaceutical space present both opportunities for modeling and challenges arising in the ever-changing landscape of federal pharmaceutical law and regulation. To illustrate how we…
read moreMany people who play touch football at their local high school or have taken their kids to youth soccer practice at the community park are familiar with artificial turf. Artificial…
read moreBob Reville, Praedicat’s CEO, is interviewed by Business Reporter. In the video interview, he describes Praedicat’s approach to emerging risk identification using a methodology based on peer-reviewed scientific literature and…
read more